BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27082639)

  • 1. Thrombosis recanalization by paeoniflorin through the upregulation of urokinase‑type plasminogen activator via the MAPK signaling pathway.
    Ye S; Mao B; Yang L; Fu W; Hou J
    Mol Med Rep; 2016 Jun; 13(6):4593-8. PubMed ID: 27082639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paeonol enhances thrombus recanalization by inducing vascular endothelial growth factor 165 via ERK1/2 MAPK signaling pathway.
    Ye S; Liu X; Mao B; Yang L; Liu N
    Mol Med Rep; 2016 Jun; 13(6):4853-8. PubMed ID: 27082415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paeoniflorin protects pancreatic β cells from STZ-induced damage through inhibition of the p38 MAPK and JNK signaling pathways.
    Liu Y; Han J; Zhou Z; Li D
    Eur J Pharmacol; 2019 Jun; 853():18-24. PubMed ID: 30880178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect.
    Yu J; Xiao Z; Zhao R; Lu C; Zhang Y
    Life Sci; 2017 Jul; 180():17-22. PubMed ID: 28456711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paeoniflorin improves pressure overload-induced cardiac remodeling by modulating the MAPK signaling pathway in spontaneously hypertensive rats.
    Liu X; Chen K; Zhuang Y; Huang Y; Sui Y; Zhang Y; Lv L; Zhang G
    Biomed Pharmacother; 2019 Mar; 111():695-704. PubMed ID: 30611994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paeoniflorin attenuates the neuroinflammatory response in a rat model of chronic constriction injury.
    Zhou J; Wang J; Li W; Wang C; Wu L; Zhang J
    Mol Med Rep; 2017 May; 15(5):3179-3185. PubMed ID: 28339077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultraviolet-A irradiation upregulated urokinase-type plasminogen activator in pterygium fibroblasts through ERK and JNK pathways.
    Chao SC; Hu DN; Yang PY; Lin CY; Nien CW; Yang SF; Roberts JE
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):999-1007. PubMed ID: 23322578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of paeoniflorin against cobalt chloride-induced apoptosis of endothelial cells via HIF-1α pathway.
    Ji Q; Yang L; Zhou J; Lin R; Zhang J; Lin Q; Wang W; Zhang K
    Toxicol In Vitro; 2012 Apr; 26(3):455-61. PubMed ID: 22269387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
    Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
    J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression.
    Yu J; Bian D; Mahanivong C; Cheng RK; Zhou W; Huang S
    J Biol Chem; 2004 Nov; 279(48):50446-54. PubMed ID: 15371454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.
    Smith PC; Santibañez JF; Morales JP; Martinez J
    J Periodontal Res; 2004 Dec; 39(6):380-7. PubMed ID: 15491342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
    Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
    Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeoniflorin upregulates β-defensin-2 expression in human bronchial epithelial cell through the p38 MAPK, ERK, and NF-κB signaling pathways.
    Gan Y; Cui X; Ma T; Liu Y; Li A; Huang M
    Inflammation; 2014 Oct; 37(5):1468-75. PubMed ID: 24700312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of TGP on KGF‑induced hyperproliferation of HaCaT cells via suppression of the p38 MAPK/NF‑κB p65 pathway.
    Pang W; Qi X; Cao C; Zhang S
    Mol Med Rep; 2018 Aug; 18(2):2207-2215. PubMed ID: 29916542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paeoniflorin inhibits tributyltin chloride-induced apoptosis in hypothalamic neurons via inhibition of MKK4-JNK signaling pathway.
    Cong C; Kluwe L; Li S; Liu X; Liu Y; Liu H; Gui W; Liu T; Xu L
    J Ethnopharmacol; 2019 Jun; 237():1-8. PubMed ID: 30878547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway.
    Dong H; Li R; Yu C; Xu T; Zhang X; Dong M
    Neuroscience; 2015 Jan; 285():70-80. PubMed ID: 25446358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
    Zheng YB; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN
    World J Gastroenterol; 2015 Jun; 21(23):7197-207. PubMed ID: 26109806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
    Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
    Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.